A proof-of-concept study of Ga-68-NOTA-3P-TATE-RGD PET/CT for dual-target imaging of somatostatin receptor and integrin alpha(v)beta(3) to detect lung cancer in a single scan
单位:[1]China Japan Friendship Hosp, Dept Nucl Med, Beijing, Peoples R China[2]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing, Peoples R China[3]Peking Union Med Coll, Beijing, Peoples R China
第一作者单位:[1]China Japan Friendship Hosp, Dept Nucl Med, Beijing, Peoples R China[2]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing, Peoples R China[3]Peking Union Med Coll, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Zheng Yumin,Zhu Zhaohui.A proof-of-concept study of Ga-68-NOTA-3P-TATE-RGD PET/CT for dual-target imaging of somatostatin receptor and integrin alpha(v)beta(3) to detect lung cancer in a single scan[J].JOURNAL of NUCLEAR MEDICINE.2018,59:
APA:
Zheng, Yumin&Zhu, Zhaohui.(2018).A proof-of-concept study of Ga-68-NOTA-3P-TATE-RGD PET/CT for dual-target imaging of somatostatin receptor and integrin alpha(v)beta(3) to detect lung cancer in a single scan.JOURNAL of NUCLEAR MEDICINE,59,
MLA:
Zheng, Yumin,et al."A proof-of-concept study of Ga-68-NOTA-3P-TATE-RGD PET/CT for dual-target imaging of somatostatin receptor and integrin alpha(v)beta(3) to detect lung cancer in a single scan".JOURNAL of NUCLEAR MEDICINE 59.(2018)